<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Xu X</submitter><funding>Intramural NIH HHS</funding><funding>NEI NIH HHS</funding><pubmed_abstract>Commensals shape host physiology through molecular crosstalk with host receptors. Identifying specific microbial factors that causally influence host immunity is key to understanding homeostasis at the host-microbe interface and advancing microbial-based therapeutics. Here, we identify trehalose monocorynomycolate (TMCM) from &lt;i>Corynebacterium mastitidis&lt;/i> (&lt;i>C. mast&lt;/i>) as a potent stimulator of IL-17 production by γδ T cells at the ocular surface. Mechanistically, TMCM-driven IL-17 responses require both IL-1 signals and γδ TCR signaling, which also supports endogenous γδ T cell IL-1R1 expression. Notably, synthetic TMCM alone is sufficient to mimic the effect of &lt;i>C. mast&lt;/i> in inducing γδ T cell immunity and protect against pathogenic corneal infection. Our findings establish TM</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2025.03.17.643820</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11956969</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Commensal-derived Trehalose Monocorynomycolate Triggers γδ T Cell-driven Protective Ocular Barrier Immunity.</pubmed_title><pmcid>PMC11956969</pmcid><funding_grant_id>U24 EY035102</funding_grant_id><funding_grant_id>P30 EY008098</funding_grant_id><funding_grant_id>T32 EY017271</funding_grant_id><funding_grant_id>Z01 EY000184</funding_grant_id><funding_grant_id>R01 EY032482</funding_grant_id><pubmed_authors>Brandes NT</pubmed_authors><pubmed_authors>Gaud G</pubmed_authors><pubmed_authors>Schwarz B</pubmed_authors><pubmed_authors>Carr M</pubmed_authors><pubmed_authors>Shane J</pubmed_authors><pubmed_authors>Mattapallil MJ</pubmed_authors><pubmed_authors>Jiang T</pubmed_authors><pubmed_authors>Peng Z</pubmed_authors><pubmed_authors>Richards C</pubmed_authors><pubmed_authors>Gupta A</pubmed_authors><pubmed_authors>Caspi RR</pubmed_authors><pubmed_authors>Love PE</pubmed_authors><pubmed_authors>Guo J</pubmed_authors><pubmed_authors>Jittayasothorn Y</pubmed_authors><pubmed_authors>Xu B</pubmed_authors><pubmed_authors>Rigas YE</pubmed_authors><pubmed_authors>Magone MT</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Nagarajan V</pubmed_authors><pubmed_authors>St Leger AJ</pubmed_authors><pubmed_authors>Zhang A</pubmed_authors><pubmed_authors>Bohrnsen E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Commensal-derived Trehalose Monocorynomycolate Triggers γδ T Cell-driven Protective Ocular Barrier Immunity.</name><description>Commensals shape host physiology through molecular crosstalk with host receptors. Identifying specific microbial factors that causally influence host immunity is key to understanding homeostasis at the host-microbe interface and advancing microbial-based therapeutics. Here, we identify trehalose monocorynomycolate (TMCM) from &lt;i>Corynebacterium mastitidis&lt;/i> (&lt;i>C. mast&lt;/i>) as a potent stimulator of IL-17 production by γδ T cells at the ocular surface. Mechanistically, TMCM-driven IL-17 responses require both IL-1 signals and γδ TCR signaling, which also supports endogenous γδ T cell IL-1R1 expression. Notably, synthetic TMCM alone is sufficient to mimic the effect of &lt;i>C. mast&lt;/i> in inducing γδ T cell immunity and protect against pathogenic corneal infection. Our findings establish TM</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-04-14T03:24:34.677Z</modification><creation>2025-07-05T03:04:33.783Z</creation></dates><accession>S-EPMC11956969</accession><cross_references><pubmed>40166223</pubmed><doi>10.1101/2025.03.17.643820</doi></cross_references></HashMap>